7/10/2007

The FDA gave its approval to Exelon, the first skin patch to treat the dementia associated with Alzheimer's disease. Novartis said the drug is delivered through a patch instead of the already-available oral capsule form to treat mild to moderate dementia symptoms.

Related Summaries